Cellmid Limited (CDY):企業概要、財務及び戦略的SWOT分析

【英語タイトル】Cellmid Limited (CDY) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(GDPH213936FSA)・商品コード:GDPH213936FSA
・発行会社(調査会社):GlobalData
・発行日:2015年1月9日
・ページ数:25
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:オーストラリア
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

Cellmid Limited (Cellmid) is a biotechnology company. The company develops therapies and diagnostic tests for cancer, inflammation and auto-immune disorders. Its products include midkine ELISA kit, advangen international hair loss products and evolis products. Cellmid is developing three therapeutic programs such as AB102: oncology antibody, CAB101: inflammation antibody, and CMK103: cardiac ischemia. The company’s products are used for the treatment and detection of cancers, the treatment of inflammatory, autoimmune diseases, and ischemic heart disease. It partners with Biotecnol, AntiCancer Incorporated, Rodon Biologics, abcodia, pharmahungry.com, Assure Quality, BioGensis, and antitope. Cellmid is headquartered in Sydney, New South Wales, Australia.

Cellmid Limited Key Recent Developments

Oct 18, 2013: Key Antibody Patent Granted In Japan
Oct 08, 2013: Key European Patent For Anti-midkine Antibodies Granted
Mar 26, 2013: Cellmid Provides Licenses Update Of Two Cancer Diagnostic Tests
Jan 23, 2013: Cellmid Reports Positive Data From Midkine Antibody Study In Kidney Disease
Jan 21, 2013: Cellmid To Receive European Patent For Use Of Anti-Midkine Agents To Prevent And Treat Blood Vessel Obstruction

This comprehensive SWOT profile of Cellmid Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cellmid Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cellmid Limited – Key Information
Cellmid Limited – Overview
Cellmid Limited – Key Employees
Cellmid Limited – Key Employee Biographies
Cellmid Limited – Key Operational Heads
Cellmid Limited – Major Products and Services
Cellmid Limited – History
Cellmid Limited – Company Statement
Cellmid Limited – Locations And Subsidiaries
Cellmid Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cellmid Limited – Business Description
Cellmid Limited – Corporate Strategy
Cellmid Limited – SWOT Analysis
SWOT Analysis – Overview
Cellmid Limited – Strengths
Cellmid Limited – Weaknesses
Cellmid Limited – Opportunities
Cellmid Limited – Threats
Cellmid Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Cellmid Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cellmid Limited, Key Information
Cellmid Limited, Key Ratios
Cellmid Limited, Share Data
Cellmid Limited, Major Products and Services
Cellmid Limited, History
Cellmid Limited, Key Employees
Cellmid Limited, Key Employee Biographies
Cellmid Limited, Key Operational Heads
Cellmid Limited, Other Locations
Cellmid Limited, Subsidiaries
Cellmid Limited, Key Manufacturing facilities
Cellmid Limited, Key Competitors
Cellmid Limited, SWOT Analysis
Cellmid Limited, Ratios based on current share price
Cellmid Limited, Annual Ratios
Cellmid Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Cellmid Limited, Performance Chart
Cellmid Limited, Ratio Charts

★調査レポート[Cellmid Limited (CDY):企業概要、財務及び戦略的SWOT分析] (コード:GDPH213936FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Cellmid Limited (CDY):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆